A phase I study of pharmacokinetics of trastuzumab emtansine in Chinese patients with locally advanced inoperable or metastatic human epidermal growth factor receptor 2-positive breast cancer who have received prior trastuzumab-based therapy.
Medicine (Baltimore)
; 99(44): e22886, 2020 Oct 30.
Article
em En
| MEDLINE
| ID: mdl-33126339
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
/
Receptor ErbB-2
/
Trastuzumab
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article